Aion Therapeutic Inc (TSE:AION) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Aion Therapeutic Inc. has issued a bi-weekly update on its management cease trade order, stating it is still in the process of completing its annual and interim financial statements due to complications from a recent acquisition. The company has been granted an extension until October 28, 2024, by the British Columbia Securities Commission and confirms no other material changes or insolvency proceedings are affecting its status.
For further insights into TSE:AION stock, check out TipRanks’ Stock Analysis page.